# Brave Bio, Inc. — Form D

Brave Bio, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-06. The offering totals $8.8M, of which $5.3M was reported sold. Industry: Other.

## Offering

- Filed: 2021-10-06
- Form: D
- Accession: 0001886666-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $8.8M
- Amount sold: $5.3M
- Remaining: $3.5M
- Investors: 3
- Date of first sale: 2021-09-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-415847

## Issuer

- Name: Brave Bio, Inc.
- CIK: 0001886666
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 420 BOYLSTON STREET #501, BOSTON, MA, 02116
- Phone: 7188568198

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Meredith Fisher | Director | Half Moon Bay, CA |
| Jacqueline Grant | Director | Durham, NC |
| Meredith Fisher | Executive Officer | Half Moon Bay, CA |

## More

- [CIK 1886666 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1886666&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001886666-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.